Patients with suspected new bladder cancer were randomly assigned 1:1 to transurethral resection of bladder tumor or ...

Learn about cytoreductive surger, a procedure used to remove cancer that has spread throughout your abdominal cavity.

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research suggests that initial MRI imaging and biopsy could be used to reduce the time ...

Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

Bladder cancer presents through various symptoms, ranging from subtle changes to more noticeable signs. While some symptoms ...

Patients were given either standard chemotherapy (cisplatin and gemcitabine) and surgery ... cancer, are usually offered a transurethral resection of a bladder tumour (TURBT) – a surgical ...

Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name ...

A team of Northwestern scientists has developed an electroactive "scaffolding" material that improves bladder tissue ...

Bladder cancer patients ... with operable bladder cancer in their study. Patients were given either standard chemotherapy (cisplatin and gemcitabine) and surgery (530 people), or chemotherapy ...

A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...